机译:吉西他滨/富紫外框的益处患者患者患者在FOLFIRINOX早期失败后濒临覆盖物可重演或局部晚期胰腺腺癌患者
Univ Texas MD Anderson Canc Ctr Dept Surg Oncol 1400 Pressler St Houston TX 77030 USA;
Univ Texas MD Anderson Canc Ctr Dept Clin Canc Prevent Houston TX 77030 USA;
Univ Texas MD Anderson Canc Ctr Dept Radiol Houston TX 77030 USA;
Univ Texas MD Anderson Canc Ctr Dept Surg Oncol 1400 Pressler St Houston TX 77030 USA;
Univ Texas MD Anderson Canc Ctr Dept Med Oncol Houston TX 77030 USA;
Univ Texas MD Anderson Canc Ctr Dept Med Oncol Houston TX 77030 USA;
Univ Texas MD Anderson Canc Ctr Dept Med Oncol Houston TX 77030 USA;
Univ Texas MD Anderson Canc Ctr Dept Surg Oncol 1400 Pressler St Houston TX 77030 USA;
Univ Texas MD Anderson Canc Ctr Dept Surg Oncol 1400 Pressler St Houston TX 77030 USA;
Univ Texas MD Anderson Canc Ctr Dept Surg Oncol 1400 Pressler St Houston TX 77030 USA;
Univ Texas MD Anderson Canc Ctr Dept Surg Oncol 1400 Pressler St Houston TX 77030 USA;
Univ Texas MD Anderson Canc Ctr Dept Surg Oncol 1400 Pressler St Houston TX 77030 USA;
Univ Texas MD Anderson Canc Ctr Dept Surg Oncol 1400 Pressler St Houston TX 77030 USA;
chemotherapy switch; FOLFIRINOX; gemcitabine-Abraxane; neoadjuvant therapy; pancreatic ductal adenocarcinoma;
机译:吉西他滨/富紫外框的益处患者患者患者在FOLFIRINOX早期失败后濒临覆盖物可重演或局部晚期胰腺腺癌患者
机译:folfirinox与吉西滨/碧氏紫杉醇,用于新辅助治疗可重症和边界可重型胰腺头腺癌
机译:NAB-PACLITAXEL加吉西他滨的随机阶段2试验,有或没有Capecitabine和Cisplatin,在当地先进或临床可重型的胰腺癌腺癌
机译:边缘可重型胰腺癌
机译:与颅底可重型胰腺腺癌患者的痛苦治疗相比,胰腺切除术治疗中位生存率是否增加了胰腺的头部胰腺炎的患者?
机译:新辅助修饰的FOLFIRINOX与nab-紫杉醇联合吉西他滨用于已行手术切除的边缘可切除或局部晚期胰腺癌患者
机译:吉西他滨/富紫外框的益处患者患者患者在Folfirinox早期失败后患者濒临覆盖物或局部晚期的胰腺腺癌患者